Renaissance Technologies’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-147,900
Closed -$259K 3829
2025
Q1
$259K Buy
147,900
+30,800
+26% +$40.6K ﹤0.01% 2984
2024
Q4
$185K Buy
117,100
+19,900
+20% +$30.6K ﹤0.01% 3190
2024
Q3
$153K Sell
97,200
-20,900
-18% -$34.6K ﹤0.01% 3179
2024
Q2
$211K Buy
118,100
+42,600
+56% +$98.9K ﹤0.01% 3031
2024
Q1
$217K Buy
75,500
+20,900
+38% +$34.1K ﹤0.01% 3202
2023
Q4
$70K Buy
54,600
+4,500
+9% +$5.99K ﹤0.01% 3385
2023
Q3
$69K Buy
50,100
+4,000
+9% +$5.8K ﹤0.01% 3331
2023
Q2
$68K Buy
46,100
+7,300
+19% +$9.72K ﹤0.01% 3555
2023
Q1
$33K Buy
38,800
+4,000
+11% +$5.29K ﹤0.01% 3745
2022
Q4
$48K Buy
34,800
+2,400
+7% +$3.77K ﹤0.01% 3804
2022
Q3
$55K Buy
32,400
+4,300
+15% +$7.74K ﹤0.01% 3734
2022
Q2
$58K Buy
28,100
+14,760
+111% +$35.8K ﹤0.01% 3974
2022
Q1
$40K Buy
13,340
+11,110
+498% +$28.9K ﹤0.01% 3937
2021
Q4
$7K Buy
+2,230
New +$9.91K ﹤0.01% 3858
2021
Q1
Sell
-44,920
Closed -$606K 3637
2020
Q4
$606K Buy
+44,920
New +$330K ﹤0.01% 2739
2020
Q3
Sell
-29,526
Closed -$201K 3634
2020
Q2
$201K Sell
29,526
-22,122
-43% -$145K ﹤0.01% 3162
2020
Q1
$238K Buy
51,648
+3,949
+8% +$34.4K ﹤0.01% 3052
2019
Q4
$425K Buy
47,699
+7,030
+17% +$48.9K ﹤0.01% 2960
2019
Q3
$293K Buy
40,669
+5,980
+17% +$48.7K ﹤0.01% 3045
2019
Q2
$434K Buy
34,689
+7,120
+26% +$82K ﹤0.01% 3050
2019
Q1
$281K Buy
27,569
+11,562
+72% +$126K ﹤0.01% 3113
2018
Q4
$149K Buy
16,007
+11,044
+223% +$183K ﹤0.01% 3183
2018
Q3
$118K Buy
4,963
+3,963
+396% +$131K ﹤0.01% 3228
2018
Q2
$79K Sell
1,000
-75
-7% -$6.21K ﹤0.01% 3167
2018
Q1
$93K Sell
1,075
-72
-6% -$9.63K ﹤0.01% 3267
2017
Q4
$143K Buy
1,147
+784
+216% +$99.2K ﹤0.01% 3182
2017
Q3
$54K Buy
+363
New +$45.7K ﹤0.01% 3126
2017
Q2
Sell
-986
Closed -$195K 3333
2017
Q1
$195K Sell
986
-1,691
-63% -$322K ﹤0.01% 3000
2016
Q4
$723K Sell
2,677
-2,698
-50% -$877K ﹤0.01% 2657
2016
Q3
$2.13M Buy
+5,375
New +$2.21M ﹤0.01% 2148
2015
Q3
Sell
-475
Closed -$625K 3327
2015
Q2
$625K Buy
+475
New +$766K ﹤0.01% 2653

Other funds holding RGLS